Medication Integration in Treatment of Comorbid Adolescent Substance Users/Attention Deficit Hyperactivity Disorder



Status:Completed
Conditions:Neurology, Psychiatric
Therapuetic Areas:Neurology, Psychiatry / Psychology
Healthy:No
Age Range:13 - 17
Updated:4/21/2016
Start Date:November 2011
End Date:December 2014

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Family-Based Protocol for Medication Integration in Treatment of Comorbid ASU/ADHD

The goal of this project is to develop and test a brief protocol designed to systematically
integrate pharmacological interventions for Attention Deficit Hyperactivity Disorder (ADHD)
into behavioral treatment services for adolescent substance users with co-morbid ADHD in
everyday care. Primary study aims will yield proof-of-concept data on MIP feasibility and
fidelity in usual care and evidence of MIP impact on psychiatric and behavioral services
utilization, medication acceptance and compliance, and satisfaction with treatment services.


Inclusion Criteria:

- Age 13-17 years

- Caregiver able to participate in treatment

- One day of alcohol use to intoxication or illegal drug use in the past 30 days (or 30
days prior to living in a controlled environment)

- endorsement of one or more DSM-IV symptoms of Substance Use or Alcohol
Dependence/Abuse

- meet ASAM criteria for outpatient substance use treatment

- meet DSM-IV criteria for ADHD (with or without onset prior to age 7)

- not enrolled in any behavioral treatment

Exclusion Criteria:

- MDD

- Bipolar Disorder

- Mental Retardation

- PDD

- medical or psychiatric illness requiring hospitalization

- current psychotic features

- currently suicidal
We found this trial at
1
site
Roberto Clemente Center
New York, New York 10009
?
mi
from
New York, NY
Click here to add this to my saved trials